RECOVERY BIOLOGICAL WARFARE VACCINES ANTITOXIN

File: 970107_sep96_decls4_0001.txt
Page: 0001
Total Pages: 1

Subject: RECOVERY BIOLOGICAL WARFARE VACCINES ANTITOXIN                  

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: RECOVERY OF BIOLOGICAL WARFARE VACCINES -  ANTITOXIN                                            

Document Number:       1001

Folder Seq  #:         43



                                        UNCLASSIFIED
                                      nrf%nrt


                                                               DASG-HCL/HCD
                                                               14 May 91

                                    INFORMATION PAPER

        SUBJECT: Recovery of Biological Warfare Vaccines/Antitoxin (U)

        1. (U) Purpose. To provide information on the medical products
        recovered from the Area of Responsibility (AOR).

        2. (U) Facts.

            a. (U) MAJ William Cline and CPT William Whitten from the U.S.
        Army Medical Research Institute of Infectious Disease (USAMRIID)
        departed to the 47th MEDSOM in the AOR on 1 May 91 and returned with
        on hand vaccines and antitoxin on 10 May 91.

            b.       The following table shows the total number of doses of
        each product sent into the AOR and the number of doses retrieved.

                 PRODUCT               DOSES SENT       DOSES RETRIEVED


                 ANTHRAX
                 BOT TOXOID
                 BOT ANTITOXIN
                doses were continuously maintained at the 47th MEDSOM.

            c.       The anthrax vaccine is a Food and Drug Administration
        (FDA) approved product with a one year expiration date once delivered
        to the user. The botulinum toxoid and antitoxin are both FDA
        approved investigational new drugs (IND) without an expiration date.

            d.       On 17 Apr 91, the refrigeration unit housing the stocks
        of anthrax vaccine, botulinum toxoid and botulinum antitoxin
        malfunctioned. As a result, the anthrax vaccine will be held in
        suspended status until it reaches its expiration date. if an urgent
        requirement occurs prior to their expiration date, these stocks will
        be retested to determine usability. The IND botulinum toxoid and
        antitoxin will be maintained and tested periodically for usability,
roduct management procedures.

            e. t"    As a result of continual production, current levels of
        these products in the CONUS base are as             5 USC 552(b)(1)
                 ANTHRAX
                 BOT TOXOID
                 BOT ANTITOXIN
                 doses of the botulinum toxoid are in the final stages
        of potency testing prior to release by manufacturer.

                      Mrs. Francoise (x68077)/MAJ Robert Eng (x68163)
        CIASSIFIED BY: DASG-HCZ      DECLASSIFIED
        DECLASSIFY ON: OADR          ON: 12 DEC 96
                                     BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958




                                        UNCLASSIFIED

Document 1 f:/Week-36/BX003201/RECOVERY OF BIOLOGICAL WARFARE VACCINES - ANTITOXIN/recovery biological warfare vaccines antitoxin:0102971547035
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = RECOVERY OF BIOLOGICAL WARFARE VACCINES - ANTITOXIN
Folder Seq # = 43
Subject = RECOVERY BIOLOGICAL WARFARE VACCINES ANTITOXIN
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997